← Back to Screener
Estrella Immunopharma, Inc. Common Stock (ESLA)
Price$1.14
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-53.90%
Price vs S&P 500 (4W)-9.51%
VGM Score59.53
Market Capitalization$49.06M
All Metrics
Book Value / Share (Quarterly)$0.00
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.19
Price vs S&P 500 (YTD)-35.08%
EPS (TTM)$-0.35
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-0.35
EPS (Annual)$-0.35
ROI (Annual)-3080.10%
Cash / Share (Quarterly)$0.05
ROA (Last FY)-411.19%
EBITD / Share (TTM)$-0.35
ROE (5Y Avg)-661.69%
Cash Flow / Share (Annual)$-0.05
P/B Ratio341.33x
P/B Ratio (Quarterly)302.06x
ROA (TTM)-397.39%
EPS Incl Extra (Annual)$-0.35
Current Ratio (Annual)0.12x
Quick Ratio (Quarterly)0.22x
3-Month Avg Trading Volume0.15M
52-Week Price Return7.55%
52-Week High$3.15
EPS Excl Extra (Annual)$-0.35
26-Week Price Return-45.97%
Quick Ratio (Annual)0.10x
13-Week Price Return3.64%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.24x
Enterprise Value$47.13M
Cash / Share (Annual)$0.04
3-Month Return Std Dev109.45%
ROE (Last FY)-3080.10%
EPS Basic Excl Extra (Annual)$-0.35
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.35
ROI (TTM)-259.11%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-16.82%
Year-to-Date Return-26.92%
5-Day Price Return1.79%
EPS Normalized (Annual)$-0.35
ROA (5Y Avg)-218.72%
Month-to-Date Return4.59%
EBITD / Share (Annual)$-0.35
ROI (5Y Avg)-661.69%
EPS Basic Excl Extra (TTM)$-0.35
P/B Ratio (Annual)302.06x
Book Value / Share (Annual)$0.00
Price vs S&P 500 (13W)-4.62%
Beta0.85x
Revenue / Share (TTM)$0.00
ROE (TTM)-259.11%
52-Week Low$0.78
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.14
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ESLAEstrella Immunopharma, Inc. Common Stock | — | — | C | $1.14 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Estrella Immunopharma is a clinical-stage biopharmaceutical company developing ARTEMIS T-cell therapies targeting CD19 and CD22 antigens for blood cancers and solid tumors. The company's engineered cell therapy approach addresses current treatment limitations in oncology and autoimmune diseases.